Skip to main content

Articles

Page 10 of 33

  1. Accumulating evidence suggests a strong association between polycystic ovary syndrome (PCOS) and ovarian cancer (OC), but the potential molecular mechanism remains unclear. In this study, we identified previou...

    Authors: Juan Zou, Yukun Li, Nianchun Liao, Jue Liu, Qunfeng Zhang, Min Luo, Jiao Xiao, Yanhua Chen, Mengjie Wang, Kexin Chen, Juan Zeng and Zhongcheng Mo
    Citation: Journal of Ovarian Research 2022 15:30
  2. Measurement of serum CA125, an antigenic fragment of human mucin 16 (MUC16), is used to monitor the clinical progression of epithelial ovarian cancer (EOC). However, rather than simply a passive marker reflect...

    Authors: Kornél Lakatos, Germán González, Jawad Hoballah, Jeff Brooker, Sinyoung Jeong, Conor Evans, Petra Krauledat, W. Peter Hansen, Kevin M. Elias, Manish Patankar, Vilmos Fülöp, Panagiotis A. Konstantinopoulos and Daniel W. Cramer
    Citation: Journal of Ovarian Research 2022 15:28
  3. Ovarian cancer (OC) is one of the serious threats to the health of women worldwide, and accurate biomarkers are urgently demanded for early diagnosis of OC. We have previously confirmed that miR-205 promotes t...

    Authors: Zehua Zhu, Zhaojun Chen, Mingxing Wang, Min Zhang, Yiwen Chen, Xiao Yang, Changjun Zhou, Yuhua Liu, Liquan Hong and Lahong Zhang
    Citation: Journal of Ovarian Research 2022 15:27
  4. Ovarian mucinous carcinoma is a disease that requires unique treatment. But for a long time, guidelines for ovarian serous carcinoma have been used for the treatment of ovarian mucinous carcinoma. This study a...

    Authors: Li Yang, Jinfen Yu, Shuang Zhang, Yisi Shan, Yajun Li, Liugang Xu, Jinhu Zhang and Jianya Zhang
    Citation: Journal of Ovarian Research 2022 15:26
  5. Recently, long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have been identified as essential biomarkers during development of malignancies. This study was performed to study the roles of lncRNA opa-intera...

    Authors: Yujue Wang, Lingling Li, Xun Zhang and Xiaolan Zhao
    Citation: Journal of Ovarian Research 2022 15:25
  6. Cervical cancer (CC) is the fourth aggressive tumor affecting women worldwide. Circular RNA (circRNA) is enrolled in CC process. This study aims to unveil the profiles of circ_101119 (circCDK17) in cell prolif...

    Authors: Rui Chen, Fei Liang, Jun Yan and Yu Wang
    Citation: Journal of Ovarian Research 2022 15:24
  7. MTHFD2 is a folate-coupled metabolic enzyme, which has been proved to participant in the metabolic reprogramming and tumor cell-sustaining proliferative capacity. However, the function of MTHFD2 in the develop...

    Authors: Xiangrong Cui, Huancheng Su, Jiaolin Yang, Xueqing Wu, Kai Huo, Xuan Jing and Sanyuan Zhang
    Citation: Journal of Ovarian Research 2022 15:23
  8. Ovarian cancer is the most women malignancy in the whole world. It is difficult to differentiate ovarian cancers from ovarian borderline tumors because of some similar imaging findings.Radiomics study may help...

    Authors: Xuefen Liu, Tianping Wang, Guofu Zhang, Keqin Hua, Hua Jiang, Shaofeng Duan, Jun Jin and He Zhang
    Citation: Journal of Ovarian Research 2022 15:22
  9. As the leading cancer of the female reproductive tract, it is not uncommon for human papilloma virus (HPV)-associated cervical squamous cell carcinoma (HPV-CSCC) to metastasize to pelvic organs and lymph nodes...

    Authors: Yuanyuan Zhang, Xiaobo Zhang, Huan Wang and Danhua Shen
    Citation: Journal of Ovarian Research 2022 15:21
  10. Growing evidence indicates that lncRNA colon cancer-associated transcript 2 (CCAT2) is associated with cancers. However, the clinical value of CCAT2 in cervical cancer (CC) remains unclear. In this study, seru...

    Authors: Xiaoli Cao, Juan Yao, Meiqun Jia, Xianjuan Shen, Jinye Zhang and Shaoqing Ju
    Citation: Journal of Ovarian Research 2022 15:20
  11. Tripartite Motif-Containing 24 (TRIM24) is a member of the tripartite motif family. TRIM24 is claimed aberrantly activated in a number of cancers, such as breast cancer, prostate cancer and lung cancer. Howeve...

    Authors: Liwei Zhang, Hong Chen, Baijuan Ding and Wei Jiang
    Citation: Journal of Ovarian Research 2022 15:19
  12. Despite the consistency of patient age, disease stage and treatment options, the prognosis of different high-grade serous ovarian carcinoma (HGSOC) patients is different. Here, we sought to measure predictive ...

    Authors: Hua Yang, Mei Yu, Sen Zhong, Yan You and Fengzhi Feng
    Citation: Journal of Ovarian Research 2022 15:18
  13. Spalt-like transcription factor 4 (SALL4) and aldehyde dehydrogenase1 family member A1 (ALDH1A1) expressing cells have been characterized as possessing stem cell-like properties known as cancer stem cell marke...

    Authors: Mina Sharbatoghli, Parisa Shamshiripour, Fahimeh Fattahi, Elham Kalantari, Zohre Habibi Shams, Mahshid Panahi, Mehdi Totonchi, Zeynab Asadi-Lari, Zahra Madjd and Leili Saeednejad Zanjani
    Citation: Journal of Ovarian Research 2022 15:17
  14. Ovarian cancer is the most deadly deadliest gynecological tumor in the female reproductive system. Therefore, the present study sought to determine the diagnostic performance of International Ovarian Tumor Ana...

    Authors: Wen ting Xie, Yao qin Wang, Zhi sheng Xiang, Zhong shi Du, Shi xin Huang, Yi jie Chen and Li na Tang
    Citation: Journal of Ovarian Research 2022 15:15
  15. This study aims to investigate the value of the quantitative indicators of MRI in the differential diagnoses of benign, borderline, and malignant epithelial ovarian tumors (EOTs).

    Authors: Fuxia Xiao, Lin Zhang, Sihua Yang, Kun Peng, Ting Hua and Guangyu Tang
    Citation: Journal of Ovarian Research 2022 15:13
  16. The five-year overall survival (OS) of advanced-stage ovarian cancer remains nearly 25-35%, although several treatment strategies have evolved to get better outcomes. A considerable amount of heterogeneity and...

    Authors: Akash Pawar, Oindrila Roy Chowdhury, Ruby Chauhan, Sanjay Talole and Atanu Bhattacharjee
    Citation: Journal of Ovarian Research 2022 15:12
  17. Melatonin, as a free radical scavenger exhibiting genomic actions, regulates the antioxidant genes expression and apoptosis mechanisms. In polycystic ovary syndrome (PCOS) patients, an imbalance between free r...

    Authors: Fatemeh Nikmard, Elham Hosseini, Mehrdad Bakhtiyari, Mahnaz Ashrafi, Fardin Amidi and Reza Aflatoonian
    Citation: Journal of Ovarian Research 2022 15:11
  18. Ferroptosis and iron-metabolism are regulated by Long non-coding RNAs (lncRNAs) in ovarian cancer (OC). Therefore, a comprehensive analysis of ferroptosis and iron-metabolism related lncRNAs (FIRLs) in OC is c...

    Authors: Songwei Feng, Han Yin, Ke Zhang, Mei Shan, Xuan Ji, Shanhui Luo and Yang Shen
    Citation: Journal of Ovarian Research 2022 15:10
  19. Cryopreservation of ovarian tissue is a fertility-preservation option for women before gonadotoxic treatments. However, cryopreserved ovarian tissue transplantation must be performed with caution in women with...

    Authors: Tristan Zver, Sophie Frontczak, Catherine Poirot, Aurélie Rives-Feraille, Brigitte Leroy-Martin, Isabelle Koscinski, Francine Arbez-Gindre, Francine Garnache-Ottou, Christophe Roux and Clotilde Amiot
    Citation: Journal of Ovarian Research 2022 15:9
  20. Long noncoding RNAs (lncRNAs) are important regulators of gene expression and can affect a variety of physiological processes. Recent studies have shown that immune-related lncRNAs play an important role in th...

    Authors: Yao Peng, Hui Wang, Qi Huang, Jingjing Wu and Mingjun Zhang
    Citation: Journal of Ovarian Research 2022 15:8
  21. High-grade serous ovarian cancer (HGSOC) is an aggressive gynaecological malignancy and associated with poor prognosis. Here we examined the effects of miR-625-3p on proliferation, treatment, migration and inv...

    Authors: Lili Zhong, Xiumin Liu, Lixing Wang, Yu Liu, Duohan Zhang and Yinlong Zhao
    Citation: Journal of Ovarian Research 2022 15:7
  22. Epithelial ovarian cancer (EOC) is the most malignant gynecological tumor in women. This study aimed to construct and compare radiomics-clinical nomograms based on MR images in EOC prognosis prediction.

    Authors: Tianping Wang, Haijie Wang, Yida Wang, Xuefen Liu, Lei Ling, Guofu Zhang, Guang Yang and He Zhang
    Citation: Journal of Ovarian Research 2022 15:6
  23. In recent years, the endometriosis has overcome a noteworthy renaissance in the recognition of its potential. In certain patients, a demonstrable malignant progression of ectopic foci leading to development of...

    Authors: Ján Varga, Alžbeta Reviczká, Hedviga Háková, Peter Švajdler, Miroslava Rabajdová and Alexander Ostró
    Citation: Journal of Ovarian Research 2022 15:5
  24. Polycystic ovary syndrome (PCOS) is an inflammatory endocrine-metabolic disorder related to reproductive system characterized by polycystic ovarian morphology, androgen excess, and chronic anovulation. Current...

    Authors: Somaye Falahatian, Raheem Haddad and Nafiseh Pakravan
    Citation: Journal of Ovarian Research 2022 15:4
  25. Progestin-primed ovarian stimulation (PPOS) has been used in infertility cases in recent years, and several reports have stated that it has oocyte collection results similar to those of gonadotropin-releasing ...

    Authors: Haipeng Huang, Yukiko Itaya, Kouki Samejima, Shunichiro Ichinose, Tatsuya Narita, Shigetaka Matsunaga, Masahiro Saitoh and Yasushi Takai
    Citation: Journal of Ovarian Research 2022 15:2
  26. Women with advanced-stage high-grade serous ovarian cancer (HGSOC) are likely to have a bad prognosis. Relapses are common in patients even with no evidence of disease after primary treatment. We aimed to iden...

    Authors: Qiao Wang, Ying Zheng, Ping Wang, Jiawen Zhang, Hui Liu, Qingli Li, Rutie Yin, Ce Bian, Hongling Peng and Zhilan Peng
    Citation: Journal of Ovarian Research 2021 14:179
  27. Maternal metabolic disorders such as obesity and diabetes are detrimental factors that compromise fertility and the success rates of medically assisted procreation procedures. During metabolic stress, adipose ...

    Authors: Patricia G. Tremblay, Chloé Fortin and Marc-André Sirard
    Citation: Journal of Ovarian Research 2021 14:178
  28. In our previous study, we found that formyl peptide receptor 2 (FPR2) promoted the invasion and metastasis of epithelial ovarian cancer (EOC) and could be a prognostic marker for EOC. In this study, we aimed t...

    Authors: Xiaohui Xie, Juan He, Qiong Wang, Yaqiong Liu, Weiwei Chen and Kun Shi
    Citation: Journal of Ovarian Research 2021 14:177
  29. Fertility preservation using ovarian tissue cryopreservation (OTC) in patients with certain diseases, especially those needing chemo- or radiotherapy, is becoming routine in various Western countries. Our hosp...

    Authors: Jiaojiao Cheng, Xiangyan Ruan, Juan Du, Fengyu Jin, Yanglu Li, Xiaowei Liu, Husheng Wang, Muqing Gu and Alfred O. Mueck
    Citation: Journal of Ovarian Research 2021 14:176
  30. In vitro fertilization (IVF) is a well-established method to treat various causes of infertility. Some previous retrospective studies suggested a lower ovarian response in Asian women compared to Caucasian wom...

    Authors: Jennifer K. Y. Ko, Andrew Kan, Peter Leung, Vivian C. Y. Lee, Raymond H. W. Li, William Ledger and Ernest H. Y. Ng
    Citation: Journal of Ovarian Research 2021 14:175
  31. Sickle cell disease is the most common monogenetic disorder worldwide. There have been reports of endocrine dysfunction and gonadal failure among affected individuals, especially in males. The findings on ovar...

    Authors: Sunusi Rimi Garba, Christian Chigozie Makwe, Vincent Oluseye Osunkalu, Olufunto Olufela Kalejaiye, Adaiah Priscillia Soibi-Harry, Amina Umar Aliyu and Bosede Bukola Afolabi
    Citation: Journal of Ovarian Research 2021 14:174
  32. The hypothalamic-pituitary-ovarian (HPO) axis is the principal regulator of the reproductive system. The neurons in the arcuate nucleus of the hypothalamus signal the basophilic cells of the anterior pituitary...

    Authors: Stephanie Mohammed, Venkatesan Sundaram, Chalapathi R. Adidam Venkata and Nikolay Zyuzikov
    Citation: Journal of Ovarian Research 2021 14:173

    The Correction to this article has been published in Journal of Ovarian Research 2023 16:99

  33. Epithelial ovarian cancer (EOC) is an extremely aggressive and lethal carcinoma. Specific data that identify high-risk groups with uterine involvement are not available. Thus, this study aimed to evaluate a gr...

    Authors: Narges Zamani, Azam Sadat Mousavi, Setare Akhavan, Shahrzad Sheikhhasani, Somayeh Nikfar, Elham Feizabad, Elahe Rezayof and Mitra Modares Gilani
    Citation: Journal of Ovarian Research 2021 14:171
  34. Vitrification has superseded the slow freezing method for cryopreservation of oocytes, embryos, and sperm, but there are as yet no standard protocols for its use in ovarian tissue cryopreservation (OTC). Publi...

    Authors: J. Marschalek, C. Egarter, K. Nouri, S. Dekan, J. Ott, M. Frank and D. Pietrowski
    Citation: Journal of Ovarian Research 2021 14:170
  35. This study aims to validate the diagnostic accuracy of the International Ovarian Tumor Analysis (IOTA) the Assessment of Different NEoplasias in the adneXa (ADNEX) model in the preoperative diagnosis of adnexa...

    Authors: Ping He, Jing-jing Wang, Wei Duan, Chao Song, Yu Yang and Qing-qing Wu
    Citation: Journal of Ovarian Research 2021 14:169
  36. Congenital anatomic abnormalities of fallopian tubes and ovaries are rarely reported. Herein, we describe four cases of undescended ovary during laparoscopic surgery with abnormal anatomy of fallopian tube, ye...

    Authors: Weixia Wei, Wenji Luo, Qicai Hu, Liping Zeng and Ruifang Wu
    Citation: Journal of Ovarian Research 2021 14:167
  37. Lymphovascular space invasion (LVSI) is the first step of hematogenous metastasis. Exploration of the differential miRNA expression profiles between LVSI-positive and LVSI-negative ovarian cancer tissues may h...

    Authors: Jun Li, Huiran Yue, Wenzhi Li, Guohua Zhu, Tingting Zhu, Ruifang Chen and Xin Lu
    Citation: Journal of Ovarian Research 2021 14:166
  38. STAT3 and p-STAT3 are often overexpressed in various human tumours and participate in cancer development and progression. However, whether STAT3/p-STAT3 expression is associated with clinicopathologic characte...

    Authors: Shuo Gao, Wenyuan Zhang, Na Yan, Min Li, Xiaowei Mu, Huaxia Yin and Jinhua Wang
    Citation: Journal of Ovarian Research 2021 14:164
  39. Small nucleolar RNA host gene 25 (SNHG25), a long noncoding RNA, has been well-studied in epithelial ovarian cancer. However, the specific functions of SNHG25 in endometrial cancer (EC) have not been studied y...

    Authors: Yuhua He, Shuifang Xu, Yi Qi, Jinfang Tian and Fengying Xu
    Citation: Journal of Ovarian Research 2021 14:163
  40. Resistance to platinum-based chemotherapy is one of the crucial problems in ovarian cancer treatment. Ghrelin, a widely distributed peptide hormone, participates in a series of cancer progression. The aim of t...

    Authors: Yun Leng, Can Zhao, Guoliang Yan, Shuangyue Xu, Yinggui Yang, Ting Gong, Xin Li and Chenglin Li
    Citation: Journal of Ovarian Research 2021 14:162
  41. Circular RNA (circRNA) is recently found to participate in the regulation of tumor progression, including ovarian cancer. However, the application of circRNA SET domain bifurcated histone lysine methyltransfer...

    Authors: Bo Li and Lu Zhang
    Citation: Journal of Ovarian Research 2021 14:160
  42. There is an urgent need to identify potential targets in anticancer therapy to improve the survival and prognosis of patients with ovarian cancer (OC). Herein, we investigated the functional significance of ch...

    Authors: Li-Na Gao, Man Hao, Xiao-Hui Liu, Li Zhang, Yan Dong, Yu-Fang Zhang and Xiao-Chun He
    Citation: Journal of Ovarian Research 2021 14:159

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.